FDA Commissioner Robert Califf (Tom Williams/CQ Roll Call via AP Images)
FDA commissioner says drug prices are too high, calls for better evidence generation
FDA Commissioner Rob Califf told BIO CEO Rachel King on Wednesday that it’s “impossible to argue that the US is doing well in health,” highlighting …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
